395
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Hearing preservation using topical dexamethasone alone and associated with hyaluronic acid in cochlear implantation

, , , , , & show all
Pages 473-477 | Received 04 Oct 2014, Accepted 01 Dec 2014, Published online: 26 Feb 2015

References

  • MLCarlson, CLWDriscoll, RHGifford, GJService, NMTombers, BJHughes-Borst, et al. Implications of minimizing trauma during conventional cochlear implantation. Otol Neurotol 2011;32:962–8.
  • DPJames, HEastwood, RTRichardson, SJO’Leary. Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol 2008;13:86–96.
  • SSChandrasekhar. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18–23.
  • ELehnhardt. Intracochlear electrode placement facilitated by Healon. Adv Otorhinolaryngol 1993;48:62–4.
  • LGarcia-Ibanez, ARMacias, CMorera, MMRodriguez, WSzyfter, HSkarszynski, et al. An evaluation of the preservation of residual hearing with the Nucleus Contour Advance electrode. Acta Otolaryngol 2009;129:651–64.
  • RLaszig, GJRidder, MFradis. Intracochlear insertion of electrodes using hyaluronic acid in cochlear implant surgery. J Laryngol Otol 2002;116:371–2.
  • CQHuang, MTykocinski, DStathopoulos, RCowan. Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants Int 2007;8:123–47.
  • SSChandrasekhar, RYRubinstein, JAKwartler, MGatz, PEConnelly, EHuang, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521–8.
  • SBjurström, NSlepecky, CAngelborg. A histopathological study of the inner ear after the administration of hyaluronan into the middle ear of the guinea pig. Acta Otolaryngol Suppl 1987;442:62–5.
  • OASelivanova, HGouveris, AVictor, RGAmedee, WMann. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière’s-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890–5.
  • TRVan de Water, CTDinh, RVivero, GHoosien, AAEshraghi, TJBalkany. Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic. Acta Otolaryngol 2010;130:308–11.
  • JKiefer, WGstoettner, WBaumgartner, SMPok, JTillein, QYe, et al. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272–80.
  • AChang, HEastwood, DSly, DJames, RRichardson, SO’Leary. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67–72.
  • GPRajan, JKuthubutheen, NHedne, JKrishnaswamy. The role of preoperative, intratympanic glucocorticoids for hearing preservation in cochlear implantation: a prospective clinical study. Laryngoscope 2012;122:190–5.
  • BJGantz, CTurner, KEGfeller. Acoustic plus electric speech processing: preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant. Audiol Neurootol 2006;11:63–8.
  • TLenarz, TStöver, ABuechner, ALesinski-Schiedat, JPatrick, JPesch. Hearing conservation surgery using the Hybrid-L electrode. Results from the first clinical trial at the Medical University of Hannover. Audiol Neurootol 2009;14:22–31.
  • WDi Nardo, ICantore, FCianfrone, PMelillo, MRigante, GPaludetti. Residual hearing thresholds in cochlear implantation and reimplantation. Audiol Neurootol 2007;12:165–9.
  • MLenarz, HSönmez, GJoseph, ABüchner, TLenarz. Effect of gender on the hearing performance of adult cochlear implant patients. Laryngoscope 2012;122:1126–9.
  • AD’Elia, RBartoli, FGiagnotti, NQuaranta. The role of hearing preservation on electrical thresholds and speech performances in cochlear implantation. Otol Neurotol 2012;33:343–7.
  • WGstoettner, JKiefer, W-DBaumgartner, SPok, SPeters, OAdunka. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.